THE protocol for one of the current Pharmacy Trial Program research projects currently under way as part of the 6CPA has been published this week in the BMY Open journal.
The project aims to investigate the feasibility of a culturally appropriate Indigenous Medication Review Service (IMeRSe) in Australia, which would be delivered by community pharmacists in collaboration with Aboriginal health workers.
The abstract notes that the age-adjusted rate of potentially preventable hospitalisations for Aboriginal and Torres Strait Islander people is almost five times the rate of other Australians, with Quality Use of Medicines playing a key role in alleviating these differences.
The full protocol is now available online at bmjopen.bmj.com.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Nov 18
